首页> 外文期刊>Journal of the American Chemical Society >Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein Receptor
【24h】

Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein Receptor

机译:通过紧凑配体的Asialoglycoprotein受体的多价展示有效的肝靶向。

获取原文
获取原文并翻译 | 示例
       

摘要

A compact and stable bicyclic bridged ketal was developed as a ligand for the asialoglycoprotein receptor (ASGPR). This compound showed excellent ligand efficiency, and the molecular details of binding were revealed by the first X-ray crystal structures of ligand-bound ASGPR. This analogue was used to make potent di- and trivalent binders of ASGPR. Extensive characterization of the function of these compounds showed rapid ASGPR-dependent cellular uptake in vitro and high levels of liver/plasma selectivity in vivo. Assessment of the biodistribution in rodents of a prototypical Alexa647-labeled trivalent conjugate showed selective hepatocyte targeting with no detectable distribution in nonparenchymal cells. This molecule also exhibited increased ASGPR-directed hepatocellular uptake and prolonged retention compared to a similar GalNAc derived trimer conjugate. Selective release in the liver of a passively permeable small-molecule cargo was achieved by retro-Diels-Alder cleavage of an oxanorbornadiene linkage, presumably upon encountering intracellular thiol. Therefore, the multicomponent construct described here represents a highly efficient delivery vehicle to hepatocytes.
机译:开发了紧凑而稳定的双环桥缩酮作为去唾液酸糖蛋白受体(ASGPR)的配体。该化合物显示出优异的配体效率,并且结合的分子细节由配体结合的ASGPR的第一X射线晶体结构揭示。该类似物用于制备ASPGR的有效二价和三价结合剂。这些化合物功能的广泛表征显示出快速的ASGPR依赖性细胞体外吸收和体内高水平的肝/血浆选择性。对典型的Alexa647标记的三价结合物在啮齿动物中的生物分布进行评估,结果表明,选择性肝细胞靶向治疗在非实质细胞中没有可检测的分布。与类似的GalNAc衍生的三聚体缀合物相比,该分子还显示出ASGPR定向的肝细胞摄取增加和保留时间延长。被动渗透的小分子货物在肝脏中的选择性释放是通过逆Diels-Alder裂解恶臭降冰片二烯键实现的,大概是在遇到细胞内硫醇时。因此,本文所述的多组分构建体代表了肝细胞的高效递送载体。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2017年第9期|3528-3536|共9页
  • 作者单位

    School of Chemistry & Biochemistry, Georgia Institute of Technology, 901 Atlantic Avenue, Atlanta, Georgia 30332, United States ,Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States;

    School of Chemistry & Biochemistry, Georgia Institute of Technology, 901 Atlantic Avenue, Atlanta, Georgia 30332, United States ,Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States;

    Pfizer Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Drug Safety R&D, Eastern Point Road, Groton, Connecticut 06340, United States;

    Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States;

    Pfizer Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Medicine Design, Main Street, Cambridge, Massachusetts 02139, United States;

    Pfizer CVMET Biology, Main Street, Cambridge, Massachusetts 02139, United States;

    Pfizer Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Drug Safety R&D, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer CVMET Biology, Main Street, Cambridge, Massachusetts 02139, United States;

    Pfizer Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer CVMET Biology, Main Street, Cambridge, Massachusetts 02139, United States;

    Pfizer Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Medicinal Sciences, Eastern Point Road, Groton, Connecticut 06340, United States;

    Pfizer Medicine Design, Main Street, Cambridge, Massachusetts 02139, United States;

    Pfizer Medicine Design, Main Street, Cambridge, Massachusetts 02139, United States;

    Pfizer Medicine Design, Main Street, Cambridge, Massachusetts 02139, United States;

    Pfizer Medicine Design, Main Street, Cambridge, Massachusetts 02139, United States;

    School of Chemistry & Biochemistry, Georgia Institute of Technology, 901 Atlantic Avenue, Atlanta, Georgia 30332, United States ,Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States;

    Pfizer Medicine Design, Eastern Point Road, Groton, Connecticut 06340, United States;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:07:56

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号